S
SinoMab BioScience Ltd
HKEX:3681
SinoMab BioScience Ltd
HKEX:3681
Price:
1.65
HKD
-4.07%
Market Cap:
HK$2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SinoMab BioScience Ltd
HKEX:3681
|
HK |
|
P
|
Papyrus Australia Ltd
ASX:PPY
|
AU |
|
B
|
Beijing Shougang Co Ltd
SZSE:000959
|
CN |
|
TVS Motor Company Ltd
NSE:TVSMOTOR
|
IN |
|
DBV Technologies SA
PAR:DBV
|
FR |
|
S
|
Solvay SA
XBER:SOL
|
BE |
|
M
|
Musk Metals Corp
CNSX:MUSK
|
CA |
|
Proximus NV
XBRU:PROX
|
BE |
|
Mahamaya Steel Industries Ltd
NSE:MAHASTEEL
|
IN |
|
Bharat Forge Ltd
NSE:BHARATFORG
|
IN |
|
P
|
Peptron Inc
KOSDAQ:087010
|
KR |
|
Adicet Bio Inc
NASDAQ:ACET
|
US |
|
A
|
ARway Corp
CNSX:ARWY
|
CA |
|
Beijing-Shanghai High Speed Railway Co Ltd
SSE:601816
|
CN |
Multiples-Based Value
The Multiples-Based Value of one SinoMab BioScience Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 1.65 HKD, SinoMab BioScience Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SinoMab BioScience Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
SinoMab BioScience Ltd Competitors
SinoMab BioScience Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
S
|
SinoMab BioScience Ltd
HKEX:3681
|
2.3B HKD | 0 | -13.9 | -15.9 | -15.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.5B USD | 6.1 | 89.7 | 14.8 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.7B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
176.3B USD | 6 | 20.7 | 12.9 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.5B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.2B USD | 5.7 | 18 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 32.7 | 11 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
